Professional Summary
Education & Certifications
- Board Certification: American Board of Internal Medicine, Critical Care Medicine (2015)
- Fellowship: University of California - San Francisco (2014) CA
- Board Certification: American Board of Emergency Medicine, Emergency Medicine (2013)
- Residency: University of California - San Francisco (2012) CA
- Medical Education: University of California - San Francisco (2008) CA
- MS, University of California-Berkeley, School of Public Health, Health & Medical Sciences (2006)
Publications
-
Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome
Liu, K. D., Wilson, J. G., Zhuo, H., Caballero, L., McMillan, M. L., Fang, X., … Matthay, M. A. (2014). Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. ANNALS OF INTENSIVE CARE, 4. -
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
Wilson, J. G., Liu, K. D., Zhuo, H., Caballero, L., McMillan, M., Fang, X., … Matthay, M. A. (2015). Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. The Lancet. Respiratory Medicine, 3(1), 24–32. -
Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia
Asmussen, S., Ito, H., Traber, D. L., Lee, J. W., Cox, R. A., Hawkins, H. K., … Enkhbaatar, P. (2014). Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. THORAX, 69(9), 819–25. -
Evolving practices in critical care and their influence on acute kidney injury
Wilson, J. G., Butcher, B. W., & Liu, K. D. (2013). Evolving practices in critical care and their influence on acute kidney injury. CURRENT OPINION IN CRITICAL CARE, 19(6), 523–30. -
Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care
Walter, J. M., Wilson, J., & Ware, L. B. (2014). Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care. EXPERT REVIEW OF RESPIRATORY MEDICINE, 8(5), 573–86. -
Critical Care Ultrasound: A Review for Practicing Nephrologists
Wilson, J. G., & Breyer, K. E. W. (2016). Critical Care Ultrasound: A Review for Practicing Nephrologists. ADVANCES IN CHRONIC KIDNEY DISEASE, 23(3), 141–45. -
OBLIQUE-AXIS VS. SHORT-AXIS VIEW IN ULTRASOUND-GUIDED CENTRAL VENOUS CATHETERIZATION
Wilson, J. G., Berona, K. M., Stein, J. C., & Wang, R. (2014). OBLIQUE-AXIS VS. SHORT-AXIS VIEW IN ULTRASOUND-GUIDED CENTRAL VENOUS CATHETERIZATION. JOURNAL OF EMERGENCY MEDICINE, 47(1), 45–50. -
Cardiac tamponade.
Wilson, J. G., Epstein, S. M., Wang, R., & Kanzaria, H. K. (2013). Cardiac tamponade. The Western Journal of Emergency Medicine, 14(2), 152-? -
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
Matthay, M. A., Calfee, C. S., Zhuo, H., Thompson, B. T., Wilson, J. G., Levitt, J. E., … Liu, K. D. (2019). Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. LANCET RESPIRATORY MEDICINE, 7(2), 154–62. -
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults
Langelier, C., Kalantar, K. L., Moazed, F., Wilson, M. R., Crawford, E. D., Deiss, T., … DeRisi, J. L. (2018). Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 115(52), E12353–E12362. -
Mechanical Ventilation in Hypoxemic Respiratory Failure.
Kapil, S., & Wilson, J. G. (2019). Mechanical Ventilation in Hypoxemic Respiratory Failure. Emergency Medicine Clinics of North America, 37(3), 431–44. -
End-of-Life Care, Palliative Care Consultation, and Palliative Care Referral in the Emergency Department: A Systematic Review.
Wilson, J. G., English, D. P., Owyang, C. G., Chimelski, E. A., Grudzen, C. R., Wong, H.-N., & Aslakson, R. A. (2019). End-of-Life Care, Palliative Care Consultation, and Palliative Care Referral in the Emergency Department: A Systematic Review. Journal of Pain and Symptom Management. -
Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients.
Ginde, A. A., Brower, R. G., Caterino, J. M., Finck, L., Banner-Goodspeed, V. M., Grissom, C. K., … Talmor, D. (2019). Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients. The New England Journal of Medicine. -
ARDS Subphenotypes: Understanding a Heterogeneous Syndrome.
Wilson, J. G., & Calfee, C. S. (2020). ARDS Subphenotypes: Understanding a Heterogeneous Syndrome. Critical Care (London, England), 24(1), 102. -
Characteristics of Adult Outpatients and Inpatients with COVID-19-11 Academic Medical Centers, United States, March-May 2020
Tenforde, M. W., Rose, E. B., Lindsell, C. J., Shapiro, N., Files, D. C., Gibbs, K. W., … Feldstein, L. R. (2020). Characteristics of Adult Outpatients and Inpatients with COVID-19-11 Academic Medical Centers, United States, March-May 2020. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 69(26), 841–46. -
Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
Wilson, J. G., Simpson, L. J., Ferreira, A.-M., Rustagi, A., Roque, J. A., Asuni, A., … Rogers, A. J. (2020). Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight. -
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., … Feldstein, L. R. (2020). Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR. Morbidity and Mortality Weekly Report, 69(30), 993–98. -
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults >= 18Years in 11 Outpatient Health Care Facilities - United States, July 2020
Fisher, K. A., Tenforde, M. W., Feldstein, L. R., Lindsell, C. J., Shapiro, N., Files, D. C., … Self, W. H. (2020). Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults >= 18Years in 11 Outpatient Health Care Facilities - United States, July 2020. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 69(36), 1258–64. -
Telework Before Illness Onset Among Symptomatic Adults Aged =18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020.
Fisher, K. A., Olson, S. M., Tenforde, M. W., Feldstein, L. R., Lindsell, C. J., Shapiro, N. I., … Self, W. H. (2020). Telework Before Illness Onset Among Symptomatic Adults Aged =18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020. MMWR. Morbidity and Mortality Weekly Report, 69(44), 1648–53. -
Metagenomic comparison of tracheal aspirate and mini-bronchial alveolar lavage for assessment of respiratory microbiota
Kalantar, K. L., Moazed, F., Christenson, S. C., Wilson, J., Deiss, T., Belzer, A., … Langelier, C. (2019). Metagenomic comparison of tracheal aspirate and mini-bronchial alveolar lavage for assessment of respiratory microbiota. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 316(3), L578–L584. -
Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States.
Fisher, K. A., Olson, S. M., Tenforde, M. W., Self, W. H., Wu, M., Lindsell, C. J., … Feldstein, L. R. (2021). Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States. Influenza and Other Respiratory Viruses. -
Effect of emergency critical care nurses and emergency department boarding time on in-hospital mortality in critically ill patients.
Nesbitt, J., Mitarai, T., Chan, G. K., Wilson, J. G., Niknam, K., Nudelman, M. J., … Kohn, M. A. (2020). Effect of emergency critical care nurses and emergency department boarding time on in-hospital mortality in critically ill patients. The American Journal of Emergency Medicine, 41, 120–24. -
Retrospective Analysis of Peri-Intubation Hypoxemia During the Coronavirus Disease 2019 Epidemic Using a Protocol for Modified Airway Management.
Madhok, J., Vogelsong, M. A., Lee, T. C., Wilson, J. G., & Mihm, F. (2020). Retrospective Analysis of Peri-Intubation Hypoxemia During the Coronavirus Disease 2019 Epidemic Using a Protocol for Modified Airway Management. A&A Practice, 14(14), e01360. -
eccSOFA: SOFA illness severity score adapted to predict in-hospital mortality in emergency critical care patients.
Niknam, K., Nesbitt, J., Mitarai, T., Nudelman, M. J., Gordon, A. J., Wilson, J. G., & Kohn, M. A. (2020). eccSOFA: SOFA illness severity score adapted to predict in-hospital mortality in emergency critical care patients. The American Journal of Emergency Medicine, 41, 145–51. -
Point-of-Care Lung Ultrasound Pattern in Healthy Parturients: Prevalence of Pulmonary Interstitial Syndrome Following Vaginal Delivery, Elective and Unplanned Intrapartum Cesarean Delivery.
Macias, P., Wilson, J. G., Austin, N. S., Guo, N., Carvalho, B., & Ortner, C. M. (2021). Point-of-Care Lung Ultrasound Pattern in Healthy Parturients: Prevalence of Pulmonary Interstitial Syndrome Following Vaginal Delivery, Elective and Unplanned Intrapartum Cesarean Delivery. Anesthesia and Analgesia. -
ICU Bed Utilization During the Coronavirus Disease 2019 Pandemic in a Multistate Analysis-March to June 2020.
Douin, D. J., Ward, M. J., Lindsell, C. J., Howell, M. P., Hough, C. L., Exline, M. C., … Ginde, A. A. (2021). ICU Bed Utilization During the Coronavirus Disease 2019 Pandemic in a Multistate Analysis-March to June 2020. Critical Care Explorations, 3(3), e0361. -
COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone.
Sarma, A., Christenson, S., Mick, E., Deiss, T., DeVoe, C., Pisco, A., … Langelier, C. (2021). COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone. Research Square. -
Adults Hospitalized with COVID-19 -United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
Sami, S., Tenforde, M. W., Talbot, H. K., Lindsell, C. J., Steingrub, J. S., Shapiro, N. I., … Patel, M. M. (2021). Adults Hospitalized with COVID-19 -United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. -
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged >= 65 Years - United States, January-March 2021
Tenforde, M. W., Olson, S. M., Self, W. H., Talbot, H. K., Lindsell, C. J., Steingrub, J. S., … Patel, M. M. (2021). Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged >= 65 Years - United States, January-March 2021. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 70(18), 674–79. -
Prospective validation of an 11-gene mRNA host response score for mortality risk stratification in the intensive care unit.
Moore, A. R., Roque, J., Shaller, B. T., Asuni, T., Remmel, M., Rawling, D., … Rogers, A. J. (2021). Prospective validation of an 11-gene mRNA host response score for mortality risk stratification in the intensive care unit. Scientific Reports, 11(1), 13062. -
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
Tenforde, M. W., Patel, M. M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., … Self, W. H. (2021). Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. -
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Goligher, E. C., Bradbury, C. A., McVerry, B. J., Lawler, P. R., Berger, J. S., Gong, M. N., … Zhong, Y. (2021). Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. The New England Journal of Medicine. -
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Lawler, P. R., Goligher, E. C., Berger, J. S., Neal, M. D., McVerry, B. J., Nicolau, J. C., … Zampieri, F. G. (2021). Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. The New England Journal of Medicine. -
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
Tenforde, M. W., Patel, M. M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., … Self, W. H. (2021). Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. MedRxiv : the Preprint Server for Health Sciences. -
Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS.
Sarma, A., Christenson, S. A., Byrne, A., Mick, E., Pisco, A. O., DeVoe, C., … Langelier, C. R. (2021). Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS. Nature Communications, 12(1), 5152. -
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021
Tenforde, M. W., Self, W. H., Naioti, E. A., Ginde, A. A., Douin, D. J., Olson, S. M., … Patel, M. M. (2021). Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 70(34), 1156–1162. -
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021
Self, W. H., Tenforde, M. W., Rhoads, J. P., Gaglani, M., Ginde, A. A., Douin, D. J., … Busse, L. W. (2021). Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 70(38), 1337–1343. -
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
Tenforde, M. W., Self, W. H., Adams, K., Gaglani, M., Ginde, A. A., McNeal, T., … Patel, M. M. (2021). Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. JAMA. -
Natural language processing of head CT reports to identify intracranial mass effect: CTIME algorithm.
Gordon, A. J., Banerjee, I., Block, J., Winstead-Derlega, C., Wilson, J. G., Mitarai, T., … Kohn, M. A. (2021). Natural language processing of head CT reports to identify intracranial mass effect: CTIME algorithm. The American Journal of Emergency Medicine, 51, 388–392. -
Effectiveness of mRNA vaccines in preventing COVID-19 hospitalization by age and burden of chronic medical conditions among immunocompetent US adults, March-August 2021.
Lewis, N. M., Naioti, E. A., Self, W. H., Ginde, A. A., Douin, D. J., Talbot, H. K., … Tenforde, M. W. (1800). Effectiveness of mRNA vaccines in preventing COVID-19 hospitalization by age and burden of chronic medical conditions among immunocompetent US adults, March-August 2021. The Journal of Infectious Diseases. -
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Berger, J. S., Kornblith, L. Z., Gong, M. N., Reynolds, H. R., Cushman, M., Cheng, Y., … Neal, M. D. (1800). Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA, 327(3), 227–236. -
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021
Tenforde, M. W., Patel, M. M., Gaglani, M., Ginde, A. A., Douin, D. J., Talbot, H. K., … Self, W. H. (2022). Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 71(4), 118–124. -
Selection bias in estimating the relationship between prolonged ED boarding and mortality in emergency critical care patients.
Gardner, K., Gordon, A. J., Shannon, B., Nesbitt, J., Wilson, J. G., Mitarai, T., & Kohn, M. A. (2022). Selection bias in estimating the relationship between prolonged ED boarding and mortality in emergency critical care patients. Journal of the American College of Emergency Physicians Open, 3(1), e12667. -
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
Lauring, A. S., Tenforde, M. W., Chappell, J. D., Gaglani, M., Ginde, A. A., McNeal, T., … Self, W. H. (2022). Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ (Clinical Research Ed.), 376, e069761. -
mRNA Vaccine Effectiveness Against COVID-19 Hospitalization Among Solid Organ Transplant Recipients.
Kwon, J. H., Tenforde, M. W., Gaglani, M., Talbot, H. K., Ginde, A. A., McNeal, T., … Self, W. H. (2022). mRNA Vaccine Effectiveness Against COVID-19 Hospitalization Among Solid Organ Transplant Recipients. The Journal of Infectious Diseases. -
Primary palliative care recommendations for critical care clinicians.
Ito, K., George, N., Wilson, J., Bowman, J., Aaronson, E., & Ouchi, K. (2022). Primary palliative care recommendations for critical care clinicians. Journal of Intensive Care, 10(1), 20. -
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022
Tenforde, M. W., Self, W. H., Gaglani, M., Ginde, A. A., Douin, D. J., Talbot, H. K., … Patel, M. M. (2022). Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 71(12), 459–465. -
Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
Tenforde, M. W., Self, W. H., Zhu, Y., Naioti, E. A., Gaglani, M., Ginde, A. A., … Patel, M. M. (2022). Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. -
Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes
Ward, M. J., Douin, D. J., Gong, W., Ginde, A. A., Hough, C. L., Exline, M. C., … Lindsell, C. J. (2022). Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes. JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 6(1). -
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
Lewis, N. M., Self, W. H., Gaglani, M., Ginde, A. A., Douin, D. J., Keipp Talbot, H., … Tenforde, M. W. (2022). Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. -
COVID-19 Acute Respiratory Distress Syndrome: One Pathogen, Multiple Phenotypes.
Empson, S., Rogers, A. J., & Wilson, J. G. (2022). COVID-19 Acute Respiratory Distress Syndrome: One Pathogen, Multiple Phenotypes. Critical Care Clinics, 38(3), 505–519. -
Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes.
Ward, M. J., Douin, D. J., Gong, W., Ginde, A. A., Hough, C. L., Exline, M. C., … Lindsell, C. J. (2022). Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes. Journal of Clinical and Translational Science, 6(1), e61. -
Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness.
Stephenson, M., Olson, S. M., Self, W. H., Ginde, A. A., Mohr, N. M., Gaglani, M., … Tenforde, M. W. (2022). Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness. Influenza and Other Respiratory Viruses. -
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
Self, W. H., Sandkovsky, U., Reilly, C. S., Vock, D. M., Gottlieb, R. L., Mack, M., … Lundgren, J. D. (2022). Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. LANCET INFECTIOUS DISEASES, 22(5), 622–635. -
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study.
Adams, K., Rhoads, J. P., Surie, D., Gaglani, M., Ginde, A. A., McNeal, T., … Self, W. H. (2022). Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. BMJ (Clinical Research Ed.), 379, e072065. -
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. (2022). Annals of Internal Medicine. -
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
Turbyfill, C., Adams, K., Tenforde, M. W., Murray, N. L., Gaglani, M., Ginde, A. A., … Patel, M. M. (2022). Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. Vaccine, 40(48), 6979–6986. -
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
Surie, D., Bonnell, L., Adams, K., Gaglani, M., Ginde, A. A., Douin, D. J., … Self, W. H. (2022). Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. MMWR. Morbidity and Mortality Weekly Report, 71(42), 1327–1334. -
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
Lewis, N. M., Murray, N., Adams, K., Surie, D., Gaglani, M., Ginde, A. A., … Patel, M. M. (2023). Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. Open Forum Infectious Diseases, 10(1), ofac698. -
Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness.
Feng, A., Yang, E. Y., Moore, A. R., Dhingra, S., Chang, S. E., Yin, X., … Utz, P. J. (2023). Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness. JCI Insight, 8(3). -
Total and subgenomic RNA viral load in patients infected with SARS-CoV-2 Alpha, Delta, and Omicron variants.
Dimcheff, D. E., Blair, C. N., Zhu, Y., Chappell, J. D., Gaglani, M., McNeal, T., … Lauring, A. S. (2023). Total and subgenomic RNA viral load in patients infected with SARS-CoV-2 Alpha, Delta, and Omicron variants. The Journal of Infectious Diseases. -
ASSOCIATION BETWEEN AN EMERGENCY CRITICAL CARE PROGRAM AND DKA CRITICAL CARE UTILIZATION IN THE ED
Gupta, P., Gordon, A. J., Mitarai, T., Nudelman, M., Kohn, M., & Wilson, J. (2023). ASSOCIATION BETWEEN AN EMERGENCY CRITICAL CARE PROGRAM AND DKA CRITICAL CARE UTILIZATION IN THE ED. CRITICAL CARE MEDICINE. LIPPINCOTT WILLIAMS & WILKINS. -
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021
Tenforde, M. W., Patel, M. M., Gaglani, M., Ginde, A. A., Douin, D. J., Talbot, H. K., … Self, W. H. (2022). Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 71(4), 118–124. -
Association of an Emergency Critical Care Program With Survival and Early Downgrade Among Critically Ill Medical Patients in the Emergency Department.
Mitarai, T., Gordon, A. J., Nudelman, M. J., Urdaneta, A. E., Nesbitt, J. L., Niknam, K., … Kohn, M. A. (2023). Association of an Emergency Critical Care Program With Survival and Early Downgrade Among Critically Ill Medical Patients in the Emergency Department. Critical Care Medicine. -
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
Self, W. H., Shotwell, M. S., Gibbs, K. W., de Wit, M., Files, D. C., Harkins, M., … Collins, S. P. (2023). Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials. JAMA, 329(14), 1170–1182. -
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
Berger, J. S., Neal, M. D., Kornblith, L. Z., Gong, M. N., Reynolds, H. R., Cushman, M., … Hochman, J. S. (2023). Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial. JAMA Network Open, 6(5), e2314428. -
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Kojima, N., Adams, K., Self, W. H., Gaglani, M., McNeal, T., Ghamande, S., … Tenforde, M. W. (2023). Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. -
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.
Surie, D., Bonnell, L. N., DeCuir, J., Gaglani, M., McNeal, T., Ghamande, S., … McMorrow, M. L. (2023). Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022. Vaccine. -
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period-IVY Network, 19 US States, February 1, 2022-January 31, 2023
DeCuir, J., Surie, D., Zhu, Y., Gaglani, M., Ginde, A. A., Douin, D. J., … Self, W. H. (2023). Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period-IVY Network, 19 US States, February 1, 2022-January 31, 2023. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 72(17), 463–468. -
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Brown, S. M., Barkauskas, C. E., Grund, B., Sharma, S., Phillips, A. N., Leither, L., … Lane, H. C. (2023). Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial. The Lancet. Respiratory Medicine. -
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 US States, February 1, 2022-January 31, 2023
DeCuir, J., Surie, D., Zhu, Y., Gaglani, M., Ginde, A. A., Douin, D. J., … Self, W. H. (2023). Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 US States, February 1, 2022-January 31, 2023. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 72(17), 463–468. -
Right Ventricular Dysfunction Patterns Among Patients with COVID-19 in the Intensive Care Unit - a Retrospective Cohort Analysis.
Sanchez, P. A., O'Donnell, C. T., Francisco, N., Santana, E. J., Moore, A. R., Pacheco-Navarro, A., … Rogers, A. J. (2023). Right Ventricular Dysfunction Patterns Among Patients with COVID-19 in the Intensive Care Unit - a Retrospective Cohort Analysis. Annals of the American Thoracic Society. -
Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.
Moore, A. R., Pienkos, S. M., Sinha, P., Guan, J., O'Kane, C. M., Levitt, J. E., … Rogers, A. J. (2023). Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials. Critical Care Medicine. -
Further advancing emergency department triage prediction.
Levin, N. M., Gordon, A. J., Htet, N., & Wilson, J. G. (2023). Further advancing emergency department triage prediction. Resuscitation, 191, 109930. -
Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections.
Feng, A., Yang, E., Moore, A., Dhingra, S., Chang, S., Yin, X., … Utz, P. (2022). Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections. Research Square. -
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged =60 Years - IVY Network, 20 US States, February 2022-May 2023
Surie, D., Yuengling, K. A., DeCuir, J., Zhu, Y., Gaglani, M., Ginde, A. A., … Self, W. H. (2023). Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged =60 Years - IVY Network, 20 US States, February 2022-May 2023. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 72(40), 1083–1088. -
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
Jensen, T. O., Grandits, G. A., Jain, M. K., Murray, T. A., Grund, B., Shaw-Saliba, K., … Ko, E. R. (2023). Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19. The Journal of Infectious Diseases. -
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
Lewis, N. M., Zhu, Y., Peltan, I. D., Gaglani, M., McNeal, T., Ghamande, S., … Self, W. H. (2023). Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. -
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Aggarwal, N. R., Nordwall, J., Braun, D. L., Chung, L., Coslet, J., Der, T., … Reilly, C. (2024). Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. -
COMMON ICU DIAGNOSES ASSOCIATED WITH EARLY ED DOWNGRADE BY A NOVEL EMERGENCY CRITICAL CARE PROGRAM
Gupta, P., Levin, N., Gordon, A., Wilson, J., & Mitarai, T. (2024). COMMON ICU DIAGNOSES ASSOCIATED WITH EARLY ED DOWNGRADE BY A NOVEL EMERGENCY CRITICAL CARE PROGRAM. CRITICAL CARE MEDICINE. LIPPINCOTT WILLIAMS & WILKINS. -
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged =65 Years - IVY Network, 18 States, September 8-November 30, 2022
Surie, D., DeCuir, J., Zhu, Y., Gaglani, M., Ginde, A. A., Douin, D. J., … Self, W. H. (2022). Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged =65 Years - IVY Network, 18 States, September 8-November 30, 2022. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 71(51-52), 1625–1630. -
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged =18 Years - VISION and IVY Networks, September 2023-January 2024.
DeCuir, J., Payne, A. B., Self, W. H., Rowley, E. A., Dascomb, K., DeSilva, M. B., … Link-Gelles, R. (2024). Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged =18 Years - VISION and IVY Networks, September 2023-January 2024. MMWR. Morbidity and Mortality Weekly Report, 73(8), 180–188. -
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
Surie, D., Yuengling, K. A., DeCuir, J., Zhu, Y., Lauring, A. S., Gaglani, M., … Self, W. H. (2024). Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults. JAMA Network Open, 7(4), e244954. -
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Jensen, T. O., Murray, T. A., Grandits, G. A., Jain, M. K., Grund, B., Shaw-Saliba, K., … Ko, E. R. (2024). Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study. The Lancet. Microbe. -
Association between emergency department disposition and mortality in patients with COVID-19 acute respiratory distress syndrome.
Lebold, K. M., Moore, A. R., Sanchez, P. A., Pacheco-Navarro, A. E., O'Donnell, C., Roque, J., … Wilson, J. G. (2024). Association between emergency department disposition and mortality in patients with COVID-19 acute respiratory distress syndrome. Journal of the American College of Emergency Physicians Open, 5(3), e13192. -
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024.
Ma, K. C., Surie, D., Lauring, A. S., Martin, E. T., Leis, A. M., Papalambros, L., … DeCuir, J. (2024). Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024. MedRxiv : the Preprint Server for Health Sciences.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Marc and Laura Andreessen Adult Emergency Department Stanford, CA
Stanford, CAMarc and Laura Andreessen Adult Emergency Department
1199 Welch Road
Stanford , CA 94304
More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.